Stroke study: Implantable Loop Recorder
Official title B2AD-Risk AFDAS Evolution of Burden of AF
ClinicalTrials.gov ID: NCT06589700
What this study is testing
- What it's testing
- The study aims to understand how atrial fibrillation (an irregular heartbeat) progresses after a stroke. It looks at how the condition worsens and how it affects heart health markers.
- Who it's for
- The study is looking for people who have had a stroke and were recently diagnosed with atrial fibrillation.
- What's involved
- Participants will have regular check-ups to monitor their heart rhythm, blood tests, and heart size. They will be grouped based on how their heart condition was first detected.
- Time commitment
- The study lasts up to 24 months and requires regular visits for assessments.
- Time commitment: about 24 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients with cortical or subcortical, cryptogenic or non-cryptogenic acute ischemic stroke
- Paroxysmal AF known before stroke onset (KAF).
- Paroxysmal AF found on an admission or Emergency Department ECG (ECG-AFDAS)
- Paroxysmal AF found on 14-day Holter monitoring (PCM-AFDAS)
You likely can't join if
- Patients not willing to consent
- Permanent or persistent AF
- Allergy to iodinated contrast agents
The study team makes the final eligibility decision.
Where it is enrolling
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at London, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.